Global Prenatal Testing & Newborn Screening Market Report 2022 – Market Forecast, Trends And Strategies
15 Feb, 2022
The global prenatal testing & newborn screening market size is expected to grow from $4.49 billion in 2021 to $5.04 billion in 2022 at a compound annual growth rate (CAGR) of 12.2%. The growth in the market is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The prenatal testing and newborn screening market is expected to reach $7.98 billion in 2026 at a CAGR of 12.2%.
What is the Global Prenatal Testing & Newborn Screening Market?
The prenatal testing and newborn screening tests market consists of sales of prenatal testing and newborn screening tests services and related goods by entities (organizations, sole traders and partnerships) that provide prenatal testing and newborn screening tests, which help to determine various genetic and chromosomal diseases, to provide timely medical or surgical treatment of a condition before or after birth. Genetic diseases such as sickle cell, down’s syndrome, cystic fibrosis and muscular dystrophy are detected with the help of these tests. Only goods and services traded between entities or sold to end consumers are included.
Get a Sample of the global prenatal testing & newborn screening market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3350&type=smp
What drives the Global Prenatal Testing & Newborn Screening Market?
The high prevalence of genetic diseases in infants contributed to the growth of the prenatal testing and newborn screening market. According to the World Health Organization, genetic disease includes diseases such as Thalassemia, Sickle Cell Anemia, Hemophilia, Cystic Fibrosis, Tay Sachs disease, Fragile X Syndrome, Huntington’s disease. The sickle cell anemia is one of the genetic diseases that affects millions throughout the world, and the disease is particularly common among people whose ancestors are from Africa, America, Cuba, Central America, Saudi Arabia, India. The high prevalence of genetic diseases in infants boosted the demand for prenatal testing and newborn screening market.
Get the full global prenatal testing & newborn screening industry report here:
https://www.thebusinessresearchcompany.com/report/prenatal-testing-and-newborn-screening-global-marketGlobal Prenatal Testing & Newborn Screening Market Segments
The global prenatal testing & newborn screening market is segmented:
By Diagnostic Type: Non-Invasive, Invasive
By Technology: Screening Technology, Diagnostic Technology
By End User: Hospitals, Diagnostic Centers
By Geography: The regions covered in the prenatal testing & newborn screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Prenatal Testing & Newborn Screening Global Market Report 2022provides market size and growth forecasts for the global prenatal testing & newborn screening market, global prenatal testing & newborn screening market share, prenatal testing & newborn screening market segments and geographies, prenatal testing & newborn screening market competitive landscape including leading competitors’ revenues, profiles and market shares. The prenatal testing & newborn screening market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Global Prenatal Testing & Newborn Screening Industry Playersinclude PerkinElmer, Progenity, Laboratory Corporation of America Holdings (Sequenom), Natera, Invitae, Centogene, Cradle Genomics, Roche Diagnostics, Quest Diagnostics and Baebies. Based on industry trends and company analysis, the report explains a number of strategies for companies in the market.